About: covid:arg/ec408739d9a284c326bc57a0699c293356df6e6c/0

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:arg/ec408739d9a284c326bc57a0699c293356df6e6c/0 Goto Sponge NotDistinct Permalink

An Entity of Type : amo:Claim, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	sioca:Idea aif:I-node aif:KnowledgePosition_Statement claim
wasQuotedFrom	Inhibition of rubella virus replication by the broad-spectrum drug nitazoxanide in cell culture and in a patient with a primary immune deficiency
sioca:supports	covid:arg/ec408739d9a284c326bc57a0699c293356df6e6c/3
aif:claimText	Here we found that empiric 2 - month therapy with oral NTZ was associated in the decline / elimination of RV antigen from lesions in a PID patient with RV positive granulomas , while peginterferon treatment had no effect .
proves	covid:arg/ec408739d9a284c326bc57a0699c293356df6e6c/3
is hasSource of	nodeID://b56210136 nodeID://b56256348 nodeID://b56257544 nodeID://b56293820 nodeID://b56319364 nodeID://b56339280 nodeID://b57436888 nodeID://b57991744 nodeID://b58027536
is sioca:supports of	covid:arg/ec408739d9a284c326bc57a0699c293356df6e6c/2 covid:arg/ec408739d9a284c326bc57a0699c293356df6e6c/3
is has claim of	covid:arg/ec408739d9a284c326bc57a0699c293356df6e6c
is proves of	covid:arg/ec408739d9a284c326bc57a0699c293356df6e6c/2 covid:arg/ec408739d9a284c326bc57a0699c293356df6e6c/3

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software